Advertisement
U.S. markets closed
Advertisement

Sector 10, Inc. (SECI)

Other OTC - Other OTC Delayed Price. Currency in USD
0.00500.0000 (0.00%)
At close: 12:48PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0050
Open0.0050
Bid0.0005 x 5000
Ask0.0200 x 5000
Day's Range0.0050 - 0.0050
52 Week Range0.0021 - 0.0305
Volume2
Avg. Volume0
Market Cap1,529
Beta (5Y Monthly)-3,225.68
PE Ratio (TTM)0.05
EPS (TTM)0.1100
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for SECI

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • SECTOR 10 INC
    Analyst Report: Johnson & JohnsonJohnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women’s health. Geographically, just over half of total revenue is generated in the United States.
    Rating
    Fair Value
    Economic Moat
    10 months agoMorningstar
View more
  • We're sorry we weren't able to find anything about this topic.